Description
This recombinant human monoclonal antibody HPAB-M0129-YC recognizes KDR (VEGFR2) and blocks the combination between VEGFR2 and VEGF. HPAB-M0129-YC has inhibition effect on the HUVEC cells proliferation induced by VEGF.
Target
KDR
Target Alias Names
Kinase Insert Domain Receptor, Kinase Insert Domain Receptor (A Type III Receptor Tyrosine Kinase), Vascular Endothelial Growth Factor Receptor 2, Protein-Tyrosine Kinase Receptor Flk-1, Fetal Liver Kinase 1, EC 2.7.10.1, VEGFR2, FLK1, Tyrosine Kinase Growth Factor Receptor
Isotype/Mimetic
Humanized IgG
Animal-Derived Biomaterials Used
None
Sequence Available
No
Original Discovery Method
Human-derived phage display
Original Discovery Information Provided On Datasheet
No
Antibody/Binder Origins
Animal-free discovery, In vitro recombinant expression

